Sciele Pharma, Inc. (SCRX), a Shionogi Group Company, Announces Name Change to Shionogi Pharma, Inc.
1/12/2010 11:14:55 AM
More...
|
Sciele Pharma, Inc. (SCRX) Introduces Adrenaclick(TM) (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis
1/7/2010 10:10:09 AM
More...
|
Pivotal Study For Sciele Pharma, Inc. (SCRX)'s PSD502 -- The First Potential Treatment For Premature Ejaculation
11/19/2009 7:35:41 AM
More...
|
Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company
11/16/2009 10:36:14 AM
More...
|
Sciele Pharma, Inc. (SCRX) Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients
9/28/2009 10:08:18 AM
More...
|
Sciele Pharma, Inc. (SCRX) Announces Availability of ULESFIA(TM)
8/5/2009 9:12:33 AM
More...
|
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
7/29/2009 9:44:44 AM
More...
|
Sciele Pharma, Inc. (SCRX) Says Scraps $150 Million Plan to Buy Victory Pharma, Inc.
7/10/2009 6:41:56 AM
More...
|
Sciele Pharma, Inc. (SCRX) Announces Availability of Ulesfia (Benzyl Alcohol Lotion 5%), First Prescription Non-Neurotoxic Head Lice Treatment
7/9/2009 9:15:40 AM
More...
|
Sciele Pharma, Inc. (SCRX) Acquires Global Rights for PSD502 from Plethora Solutions Ltd.
5/26/2009 10:47:37 AM
More...
|
|